A5002029800- Acute Ischemic Stroke Management
- Stroke Rehabilitation and Recovery
- Atrial Fibrillation Management and Outcomes
- Venous Thromboembolism Diagnosis and Management
- Cerebrovascular and Carotid Artery Diseases
- Diabetic Foot Ulcer Assessment and Management
- Cardiac Arrest and Resuscitation
- Trauma and Emergency Care Studies
- Cardiac Arrhythmias and Treatments
- Intracerebral and Subarachnoid Hemorrhage Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac, Anesthesia and Surgical Outcomes
- Diagnosis and Treatment of Venous Diseases
- Cardiovascular Syncope and Autonomic Disorders
- Advanced MRI Techniques and Applications
Moses H Cone Memorial Hospital
2012-2021
Cone Health
2009-2020
University of Tennessee Health Science Center
2018
Wichita State University
2018
Central DuPage Hospital
2018
Hackensack Meridian Health
2018
The evidence base supporting the management of patients with acute stroke is evolving at a rapid rate, as new methods that aim to reduce disability and death from are explored. Intravenous tissue plasminogen activator remains only treatment shown in numerous studies 3 months after no increase risk relatively minor rate symptomatic intracerebral hemorrhage complications. Despite these findings, health care providers have been slow adopt this evidence-based treatment, which results many...
Variance from guideline-directed care for glucose and temperature control remains unknown in the United States at a time when priorities have shifted to ensure rapid diagnosis treatment of acute stroke patients. However, protocol-driven nursing surveillance hyperglycemia hyperthermia has been shown improve patient outcomes.We conducted an observational pilot study assess compliance with American guidelines association discharge outcomes consecutive patients admitted 5 US comprehensive...
The evidence base supporting the management of patients with acute stroke is evolving at a rapid rate, as new methods that aim to reduce disability and death from are explored. Intravenous tissue plasminogen activator remains only treatment shown in numerous studies 3 months after no increase risk relatively minor rate symptomatic intracerebral hemorrhage complications. Despite these findings, health care providers have been slow adopt this evidence-based treatment, which results many...
Background: In the Australian QASC Trial (Lancet 2013), better glucose and fever control improved 90 day outcomes when nurses adhered to strict monitoring/treatment protocols. We examined variance from guideline specific care for in an American sample. Methods: An observational study was conducted assess compliance with AHA/ASA stroke guidelines consecutive acute patients 5 different U.S. Stroke Centers. The first 5-days of glucose/temperature data were analyzed along demographics outcome...
Introduction: Embolic strokes related to atrial fibrillation (AF) carry significant morbidity and mortality. Identifying patients with asymptomatic AF following stroke is difficult. A protocol for incorporation of implantable loop recorders (ILR) in management has not been established. Methods: We developed a evaluation cryptogenic embolic using ILR detection (figure 1). Patients implanted were enrolled an clinic structured remote follow-up. The primary end point was time first detected AF....
Background: “Stress mediated” hyperglycemia is often assumed to drive initial during stroke admission. We sought examine hemoglobin A1c (HbA1c) in relation serum glucose. Methods: An observational design was used glucose data from prospectively admitted acute patients at 4 Comprehensive Stroke Centers. Data were entered and analyzed SPSS using descriptive statistics, student t-tests, Mann Whitney U. Results: 1226 studied; 50% male, 63% White, 34% African American (AA); age averaged 69±13.5...
Introduction: Paroxysmal afib is the most common cause of cryptogenic strokes. Long-term insertable cardiac monitor (ICM) has been increasingly used for ongoing evaluation in these patients. Due to financial affordability, it important identify appropriate candidates its routine use. Methods: We reviewed EMRs a cohort stroke patients from February 2014 May 2017 who received REVEAL LINQ ICMs. All met ESUS criteria prior insertion and were enrolled remote follow-up. At least one year...
Introduction: Cryptogenic strokes account for one third of all strokes. Atrial fibrillation has been described as a leading cause in this population but occurrence atrial and imaging charecteristics amongst recurrent have not characterized well. Methods: We reviewed electronic medical charts cohort cryptogenic patients from February 2014 to September 2017 who underwent REVEAL LINQ insertable cardiac monitor. All met ESUS( Embolic Stroke Unknown Source) criteria prior implantation were...
Background: Stroke Coordinators (SC) are commonly utilized in US Centers, ensuring provision of evidence-based service, overseeing quality improvement, and supporting interdisciplinary community education. Mission Thrombectomy 2020 (MT2020) partnered with the Association Neurovascular Clinicians (ANVC) to understand how SCs outside compare developmental needs for this role across world. Methods: A brief survey was constructed capture information about use their duties, including personnel...